Co-Diagnostics (CODX) Tops Q1 EPS by 4c, Offers Q2 Guidance
Get Alerts CODX Hot Sheet
Join SI Premium – FREE
Co-Diagnostics (NASDAQ: CODX) reported Q1 EPS of $0.26, $0.04 better than the analyst estimate of $0.22. Revenue for the quarter came in at $20 million versus the consensus estimate of $19.89 million.
GUIDANCE:
Co-Diagnostics sees Q2 2021 EPS of $0.19-$0.23, versus the consensus of $0.22. Co-Diagnostics sees Q2 2021 revenue of $20-22 million, versus the consensus of $16.3 million.
For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Grainger (GWW) Tops Q1 EPS by 2c, provides guidance
- First Merchants Corp (FRME) Tops Q1 EPS by 3c
- Independent Bank (IBCP) Tops Q1 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!